NCT03466203View on ClinicalTrials.gov

Safety Study of LLF580 in Obese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

February 26, 2018

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions
Obesity
Interventions
BIOLOGICAL

LLF580

LLF580 300mg

DRUG

Placebo

Placebo to LLF580

Trial Locations (7)

19104

Novartis Investigative Site, Philadelphia

27265

Novartis Investigative Site, High Point

32216

Novartis Investigative Site, Jacksonville

33126

Novartis Investigative Site, Miami

37920

Novartis Investigative Site, Knoxville

66212

Novartis Investigative Site, Overland Park

68502

Novartis Investigative Site, Lincoln

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY